Skip to main content
SpringerLink
Log in

Komplexe Wechselwirkungen zwischen Arzneimitteln und dem Mikrobiom

  • Pharmakomikrobiomik
  • Published:
BIOspektrum Aims and scope

Abstract

Our knowledge regarding the interplay between drugs, our microbiome, and the host has long been restricted to a few exceptional cases. Recent evidence from more systematic studies reveals that the majority of commonly used drugs underlie such interactions. This highlights the need for a more comprehensive understanding of the interface between pharmacology, microbial ecology, environmental factors, and the host genotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Blaser M (2016) Antibiotic use and its consequences for the normal microbiome. Science 352:544–545

    Article  CAS  Google Scholar 

  2. Le Bastard Q, Al-Ghalith GA, Gregoire M et al. (2018) Systematic review: human gut dysbiosis induced by nonantibiotic prescription medications. Aliment Pharmacol Ther 47:332–345

    Article  CAS  Google Scholar 

  3. Tramontano M, Andrejev S, Pruteanu M et al. (2018) Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies. Nat Microbiol 3:514–522

    Article  CAS  Google Scholar 

  4. Maier L, Pruteanu M, Kuhn M et al. (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555:623–628

    Article  CAS  Google Scholar 

  5. Maier L, Typas A (2017) Systematically investigating the impact of medication on the gut microbiome. Curr Opin Microbiol 39:128–135

    Article  CAS  Google Scholar 

  6. Spanogiannopoulos P, Bess EN, Carmody RN et al. (2016) The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol 14:273–287

    Article  CAS  Google Scholar 

  7. Sousa T, Yadav V, Zann V et al. (2014) On the colonic bacterial metabolism of azo-bonded prodrugsof 5-aminosalicylic acid. J Pharm Sci 103:3171–3175

    Article  CAS  Google Scholar 

  8. Haiser HJ, Seim KL, Balskus EP et al. (2014) Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes 5:233–238

    Article  Google Scholar 

  9. Wallace BD, Wang H, Lane KT et al. (2010) Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330:831–835

    Article  CAS  Google Scholar 

  10. Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R et al. (2019) Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570:462–467

    Article  CAS  Google Scholar 

  11. Pryor R, Martinez-Martinez D, Quintaneiro L et al. (2019) The role of the microbiome in drug response. Annu Rev Pharmacol Toxicol 6, doi: 10.1146/annurev-pharmtox-010919-023612

  12. Elkrief A, Derosa L, Zitvogel L (2019) The intimate relationship between gut microbiota and cancer immunotherapy. Gut Microbes 10:424–428

    Article  CAS  Google Scholar 

  13. Lam KN, Alexander M, Turnbaugh PJ (2019) Precision medicine goes microscopic: engineering the microbiome to improve drug outcomes. Cell Host Microbe 26:22–34

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Interfakultäres Institut für Mikrobiologie und Infektionsmedizin, Universität Tübingen, Elfriede-Aulhorn-Straße 6, D-72076, Tübingen, Deutschland

    Lisa Maier

Authors
  1. Lisa Maier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa Maier.

Additional information

Lisa Maier 2004–2009 Biochemiestudium an der Universität TÜbingen. 2010–2013 Promotion bei Prof. W.-D. Hardt an der ETH ZÜrich, Schweiz; dort 2014 Postdoc. 2015-2018 Postdoc am EMBL in Heidelberg bei Dr. A. Typas (EIPOD-Programm). Seit 2019 Gruppenleiterin an der Universität TÜbingen, Exzellenzcluster EXC 2124, Aufnahme in das Emmy-Noether-Programm der DFG

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maier, L. Komplexe Wechselwirkungen zwischen Arzneimitteln und dem Mikrobiom. Biospektrum 25, 707–710 (2019). https://doi.org/10.1007/s12268-019-1302-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12268-019-1302-9

Search

Navigation